Jaguar Land Rover is cutting up to 500 management jobs in the UK following a sharp drop in global sales and trade disruption with the US. The voluntary redundancy programme affects around 1.5% of the
Abbott Laboratories (NYSE:ABT) shares moved more than 6% lower as disappointing guidance overshadowed solid second quarter results.  The company now expects full-year earnings per share (EPS) in the
Although the revenue and EPS for Abbott (ABT) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street est
Abbott (ABT) came out with quarterly earnings of $1.26 per share, beating the Zacks Consensus Estimate of $1.25 per share. This compares to earnings of $1.14 per share a year ago.
U.S. stock futures were mostly lower this morning, with the Dow futures falling around 0.2% on Thursday.
US stocks are anticipated to be slow out of the blocks on Thursday as earnings emerged from PepsiCo and Abbott Laboratories, with retail sales and manufacturing surveys due. Dow Jones futures were dow
Abbott Laboratories stock falls even as the company reports second-quarter sales that top expectations.
Abbott beat Wall Street estimates for quarterly profit on Thursday, driven by strong demand for its medical devices including continuous glucose monitors.

Abbott Reports Second-Quarter 2025 Results

07:30am, Thursday, 17'th Jul 2025
Second-quarter reported sales growth of 7.4 percent; organic sales growth of 6.9 percent or 7.5 percent excluding COVID-19 testing-related sales1 Second-quarter GAAP diluted EPS of $1.01; adjusted dil
Abbott Laboratories ABT will release earnings results for the second quarter, before the opening bell on Thursday, July 17.
The broader market's historic rebound may make it necessary to consider some defensive positions in the portfolio, and these medical stocks fit the bill ahead of their Q2 reports.

Sell ABT Stock Ahead Of Its Q2 Earnings?

07:35am, Tuesday, 15'th Jul 2025
Abbott Laboratories (NYSE:ABT) is scheduled to announce its second-quarter earnings on Thursday, July 17, 2025. For traders who focus on events, examining the historical reactions of the stock to earn
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Abbott (ABT), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quart
Abbott eyes Q2 growth with strong CGM momentum, cardiac device wins and resilient performance across key segments.

3 Dividend Growth Stocks to Buy and Hold

06:40am, Saturday, 12'th Jul 2025
What's better than a great dividend? A great dividend that's growing.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE